FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2071351256> ?p ?o ?g. }

• W2071351256 endingPage "782" @default.
• W2071351256 startingPage "777" @default.
• W2071351256 abstract "We have conducted a Phase I trial to determine the maximum tolerated dose of CPT-11 together with a fixed dose of cisplatin in patients with advanced lung cancer, and the dose-limiting toxicities of this combination. Fourteen previously untreated patients with stage IIIB or IV disease were treated with CPT-11 (90-min intravenous infusion on days 1, 8, and 15) plus cisplatin (60 mg m-2, intravenously on day 1). The starting dose of CPT-11 was 60 mg m-2, and diarrhea was the dose-limiting toxicity at the 90 mg m-2 dose level. All three patients (all four cycles) given 90 mg m-2 of CPT-11 experienced grade 3 diarrhea. Hematologic toxicity was relatively mild. Elimination of CPT-11 was biphasic with a mean (+/- s.d.) beta half-life of 11.36 +/- 7.26 h. The mean terminal half-life of the major metabolite (7-ethyl-10-hydroxycamptothecin; SN-38) was 22.13 +/- 13.28 (s.d.) h, and modest escalation of the CPT-11 dose from 80 mg m-2 to 90 mg m-2 resulted in a statistically significant apparent increase in the plasma concentrations of SN-38. There were one complete response (7%) and five partial responses (36%) among the 14 patients for an overall response rate of 43%. The recommended dose for Phase II studies is 80 mg m-2 of CPT-11 and 60 mg m-2 of cisplatin." @default.
• W2071351256 created "2016-06-24" @default.
• W2071351256 creator A5002461553 @default.
• W2071351256 creator A5004024254 @default.
• W2071351256 creator A5017396574 @default.
• W2071351256 creator A5023792530 @default.
• W2071351256 creator A5024261346 @default.
• W2071351256 creator A5028305459 @default.
• W2071351256 creator A5030283097 @default.
• W2071351256 creator A5052287605 @default.
• W2071351256 creator A5071460846 @default.
• W2071351256 creator A5076104617 @default.
• W2071351256 date "1993-10-01" @default.
• W2071351256 modified "2023-10-10" @default.
• W2071351256 title "Phase I and pharmacologic study of irinotecan in combination with cisplatin for advanced lung cancer" @default.
• W2071351256 cites W1536538430 @default.
• W2071351256 cites W1567663060 @default.
• W2071351256 cites W1794341310 @default.
• W2071351256 cites W1851083905 @default.
• W2071351256 cites W1897082568 @default.
• W2071351256 cites W1903533038 @default.
• W2071351256 cites W1952431753 @default.
• W2071351256 cites W1975549289 @default.
• W2071351256 cites W2016722642 @default.
• W2071351256 cites W2020931366 @default.
• W2071351256 cites W2078751203 @default.
• W2071351256 cites W2159921901 @default.
• W2071351256 cites W2169186295 @default.
• W2071351256 doi "https://doi.org/10.1038/bjc.1993.427" @default.
• W2071351256 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1968602" @default.
• W2071351256 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8398707" @default.
• W2071351256 hasPublicationYear "1993" @default.
• W2071351256 type Work @default.
• W2071351256 sameAs 2071351256 @default.
• W2071351256 citedByCount "93" @default.
• W2071351256 countsByYear W20713512562015 @default.
• W2071351256 countsByYear W20713512562018 @default.
• W2071351256 crossrefType "journal-article" @default.
• W2071351256 hasAuthorship W2071351256A5002461553 @default.
• W2071351256 hasAuthorship W2071351256A5004024254 @default.
• W2071351256 hasAuthorship W2071351256A5017396574 @default.
• W2071351256 hasAuthorship W2071351256A5023792530 @default.
• W2071351256 hasAuthorship W2071351256A5024261346 @default.
• W2071351256 hasAuthorship W2071351256A5028305459 @default.
• W2071351256 hasAuthorship W2071351256A5030283097 @default.
• W2071351256 hasAuthorship W2071351256A5052287605 @default.
• W2071351256 hasAuthorship W2071351256A5071460846 @default.
• W2071351256 hasAuthorship W2071351256A5076104617 @default.
• W2071351256 hasBestOaLocation W20713512562 @default.
• W2071351256 hasConcept C112705442 @default.
• W2071351256 hasConcept C121608353 @default.
• W2071351256 hasConcept C126322002 @default.
• W2071351256 hasConcept C2776256026 @default.
• W2071351256 hasConcept C2776694085 @default.
• W2071351256 hasConcept C2778239845 @default.
• W2071351256 hasConcept C2779802037 @default.
• W2071351256 hasConcept C2780259306 @default.
• W2071351256 hasConcept C2780508388 @default.
• W2071351256 hasConcept C29730261 @default.
• W2071351256 hasConcept C31760486 @default.
• W2071351256 hasConcept C526805850 @default.
• W2071351256 hasConcept C71924100 @default.
• W2071351256 hasConcept C90924648 @default.
• W2071351256 hasConcept C98274493 @default.
• W2071351256 hasConceptScore W2071351256C112705442 @default.
• W2071351256 hasConceptScore W2071351256C121608353 @default.
• W2071351256 hasConceptScore W2071351256C126322002 @default.
• W2071351256 hasConceptScore W2071351256C2776256026 @default.
• W2071351256 hasConceptScore W2071351256C2776694085 @default.
• W2071351256 hasConceptScore W2071351256C2778239845 @default.
• W2071351256 hasConceptScore W2071351256C2779802037 @default.
• W2071351256 hasConceptScore W2071351256C2780259306 @default.
• W2071351256 hasConceptScore W2071351256C2780508388 @default.
• W2071351256 hasConceptScore W2071351256C29730261 @default.
• W2071351256 hasConceptScore W2071351256C31760486 @default.
• W2071351256 hasConceptScore W2071351256C526805850 @default.
• W2071351256 hasConceptScore W2071351256C71924100 @default.
• W2071351256 hasConceptScore W2071351256C90924648 @default.
• W2071351256 hasConceptScore W2071351256C98274493 @default.
• W2071351256 hasIssue "4" @default.
• W2071351256 hasLocation W20713512561 @default.
• W2071351256 hasLocation W20713512562 @default.
• W2071351256 hasLocation W20713512563 @default.
• W2071351256 hasLocation W20713512564 @default.
• W2071351256 hasOpenAccess W2071351256 @default.
• W2071351256 hasPrimaryLocation W20713512561 @default.
• W2071351256 hasRelatedWork W1987705191 @default.
• W2071351256 hasRelatedWork W1996694250 @default.
• W2071351256 hasRelatedWork W2027385411 @default.
• W2071351256 hasRelatedWork W2036743666 @default.
• W2071351256 hasRelatedWork W2091430838 @default.
• W2071351256 hasRelatedWork W2151112513 @default.
• W2071351256 hasRelatedWork W3003305233 @default.
• W2071351256 hasRelatedWork W3173651342 @default.
• W2071351256 hasRelatedWork W4386438526 @default.
• W2071351256 hasRelatedWork W2550413855 @default.
• W2071351256 hasVolume "68" @default.
• W2071351256 isParatext "false" @default.

• next